Search research articles
Contact Us
Filters
Showing results (101-110 of 139) with videos related to
Page
of 14
Sort By:
Medrxiv : the Preprint Server for Health Sciences
|
April 10, 2026
A circulating protein signature for predicting severe immune-related adverse events following CAR T-cell therapy in relapsed/refractory lymphoma
Ehsan Irajizad, Johannes F Fahrmann, Hiroyuki Katayama, et al.
Blood Advances
|
June 27, 2020
Bridging therapy prior to axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma
Chelsea C Pinnix, Jillian R Gunther, Bouthaina S Dabaja, et al.
Advances in Radiation Oncology
|
November 18, 2024
Early-Stage Extranodal NK/T-Cell Lymphoma, Nasal Type: A Role for Elective Nodal Irradiation?
Penny Fang, Sonal S Noticewala, Susan Y Wu, et al.
Advances in Radiation Oncology
|
November 11, 2024
Ultra-Low-Dose Radiation for Extranodal Marginal Zone Lymphoma of the Lung
Susan Y Wu, Penny Q Fang, Ahmed Fetooh, et al.
Blood Advances
|
February 5, 2025
Phase 2 trial of ibrutinib and nivolumab in patients with relapsed CNS lymphomas
Dai Chihara, Raphael E Steiner, Ranjit Nair, et al.
Blood Advances
|
June 15, 2025
A phase 2 study of obinutuzumab combined with lenalidomide in previously untreated high tumor burden follicular lymphoma
Neha Akkad, Lei Feng, Jason R Westin, et al.
Haematologica
|
November 30, 2023
Effect of delayed cell infusion in patients with large B-cell lymphoma treated with chimeric antigen receptor T-cell therapy
Andrew P Jallouk, Naishu Kui, Ryan Sun, et al.
Frontiers in Oncology
|
September 26, 2024
Outcomes and toxicities in patients with diffuse-large B cell lymphoma involving the gastrointestinal tract and digestive organs
Gohar S Manzar, Elaine E Cha, Kelsey L Corrigan, et al.
Leukemia & Lymphoma
|
January 24, 2020
Pretreatment SUV<sub>max</sub> may influence the clinical benefit of BR over R-CHOP in patients with previously untreated FL
Paolo Strati, Mohamed Amin Ahmed, Loretta J Nastoupil, et al.
Blood Advances
|
March 31, 2022
SIRPα+ macrophages are increased in patients with FL who progress or relapse after frontline lenalidomide and rituximab
Mario L Marques-Piubelli, Edwin R Parra, Lei Feng, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 139) with videos related to
Sort By:
Page
of 14
Medrxiv : the Preprint Server for Health Sciences
|
April 10, 2026
A circulating protein signature for predicting severe immune-related adverse events following CAR T-cell therapy in relapsed/refractory lymphoma
Ehsan Irajizad, Johannes F Fahrmann, Hiroyuki Katayama, et al.
Blood Advances
|
June 27, 2020
Bridging therapy prior to axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma
Chelsea C Pinnix, Jillian R Gunther, Bouthaina S Dabaja, et al.
Advances in Radiation Oncology
|
November 18, 2024
Early-Stage Extranodal NK/T-Cell Lymphoma, Nasal Type: A Role for Elective Nodal Irradiation?
Penny Fang, Sonal S Noticewala, Susan Y Wu, et al.
Advances in Radiation Oncology
|
November 11, 2024
Ultra-Low-Dose Radiation for Extranodal Marginal Zone Lymphoma of the Lung
Susan Y Wu, Penny Q Fang, Ahmed Fetooh, et al.
Blood Advances
|
February 5, 2025
Phase 2 trial of ibrutinib and nivolumab in patients with relapsed CNS lymphomas
Dai Chihara, Raphael E Steiner, Ranjit Nair, et al.
Blood Advances
|
June 15, 2025
A phase 2 study of obinutuzumab combined with lenalidomide in previously untreated high tumor burden follicular lymphoma
Neha Akkad, Lei Feng, Jason R Westin, et al.
Haematologica
|
November 30, 2023
Effect of delayed cell infusion in patients with large B-cell lymphoma treated with chimeric antigen receptor T-cell therapy
Andrew P Jallouk, Naishu Kui, Ryan Sun, et al.
Frontiers in Oncology
|
September 26, 2024
Outcomes and toxicities in patients with diffuse-large B cell lymphoma involving the gastrointestinal tract and digestive organs
Gohar S Manzar, Elaine E Cha, Kelsey L Corrigan, et al.
Leukemia & Lymphoma
|
January 24, 2020
Pretreatment SUV<sub>max</sub> may influence the clinical benefit of BR over R-CHOP in patients with previously untreated FL
Paolo Strati, Mohamed Amin Ahmed, Loretta J Nastoupil, et al.
Blood Advances
|
March 31, 2022
SIRPα+ macrophages are increased in patients with FL who progress or relapse after frontline lenalidomide and rituximab
Mario L Marques-Piubelli, Edwin R Parra, Lei Feng, et al.
Page
of 14